Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes
1 other identifier
observational
538
1 country
1
Brief Summary
Schizophrenia has long been known to be an illness with significant evidence for a genetic predisposition. The purpose of this study is to determine the genetic abnormalities that cause childhood and adult onset schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
April 14, 2005
CompletedFirst Posted
Study publicly available on registry
April 15, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedResults Posted
Study results publicly available
January 7, 2016
CompletedJanuary 7, 2016
December 1, 2015
4.9 years
April 14, 2005
November 3, 2014
December 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Genetic Linkage
Log of the Odds for Linkage, a standard genetic analysis metric. The number shown as a result is from a polymorphism in the promoter of the gene for the alpha7 nicotinic receptor on chromosome. Its presence in the individuals in this study, considering all three groups in one analysis, is compared to what of P50 sensory gating. P50 is a Positive wave in scalp-recorded auditory evoked potential that occurs 50 msec after the sound stimulus. P50 sensory gating is the decrement in this wave to the second of repeated sounds. The log of the odds is the common logarithm of the ratio of the odds that the gene polymorphism and P50 sensory gating are associated versus the odds that they are both distributed in the individuals at random. It is similar to the more common chi squared.
ten years
Heritability Coefficient
h squared which ranges from 0 to 1. This number is similar to the more standard Pearson's correlation coefficient, except that the variable, in this case P50 sensory gating, is correlated across the statuses: schizophrenia proband (has the illness), schizophrenia relative (not ill but relative of someone who is), or control (not ill and has no known ill relative, P50 is a Positive wave in scalp-recorded auditory evoked potential that occurs 50 msec after the sound stimulus. P50 sensory gating is the decrement in this wave to the second of repeated sounds.
5 years
Log of the ODDS of Linkage
Log of the ODDS ratio of Linkage divided by the ODDS of no linkage from a maximum likelihood analysis conducted using the statistical program LINKAGE
1 day
Study Arms (1)
Diagnostic
A diagnostic was performed
Interventions
Diagnostic evaluation for schizophrenia. Schizophrenia includes schizophrenia and schizoaffective disorder.
Eligibility Criteria
Persons with schizophrenia, their relatives, and controls
You may qualify if:
- Individuals thought to have schizophrenia or schizoaffective disorder, be the parent of such an individual, or be in the matched control group of unrelated individuals not thought to have schizophrenia or schizoaffective disorder
You may not qualify if:
- Unable to give informed consent;
- Psychotic disorder judged to be secondary to substance abuse, psychotic disorder that appears to be secondary to a known medical or neurological disorder, or severe mental retardation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Eastern Colorado Health Care System, Denver
Denver, Colorado, 80220, United States
Biospecimen
dna
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Genetic linkage and association do not replicate well across studies. This study should be viewed in this context.
Results Point of Contact
- Title
- Dr. Robert Freedman
- Organization
- VA
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Freedman, MD
VA Eastern Colorado Health Care System, Denver
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2005
First Posted
April 15, 2005
Study Start
January 1, 2004
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
January 7, 2016
Results First Posted
January 7, 2016
Record last verified: 2015-12